Latest News and Press Releases

TAMPA, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Inhibitor Therapeutics, Inc. ("Inhibitor") (OTCQB: INTI) today provided an update on development efforts for its itraconazole formulation for the...

New York City, NY, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Nine new leading food businesses join the U.S. Working Group for Broiler Welfare, bringing the group to 16 members. The doubling of members...

Leverkusen, Germany, June 22, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today provides an...

Election of Board of DirectorsAppoint Deloitte LLP as AuditorAppointment of OfficersIssuance of Stock OptionsEntering into Executive Services Agreement with Canadian Capital, LLC TORONTO, Nov. 02,...

TORONTO, Oct. 26, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced it has completed preparatory construction work and...

TORONTO, Oct. 24, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced that it made an initial drawdown of US$10 million under...

TORONTO, Oct. 13, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced that, the Company, through its wholly-owned U.S....

TORONTO, Sept. 28, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) reported its financial results for the first quarter of fiscal 2018,...

TORONTO, Sept. 08, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today reported its financial results for the fourth quarter and full...

Differentiation into high-growth market segment under new “Salus Bio-Pharma” brand JV will launch in Arizona & Massachusetts and, post closing of the acquisitions, in Nevada and Maryland. ...